Cannabis
ShinyBud Reschedules Fiscal Year 2022 Conference Call and Webcast for May 31, 2022
ShinyBud Corp. (“ShinyBud” or the “Company”) (TSXV: SNYB) is rescheduling the release of its fiscal year 2022 financial and operating results on Monday, May 30, 2022 to after market close at approximately 5:00 p.m. ET. The results will be available on SEDAR at www.sedar.com under ShinyBud’s profile and on the Company’s investor relations website at investors.shinybud.com. The conference call and audio webcast has also been rescheduled to Tuesday, May 31, 2022 at 8:30 a.m. ET where management will review the results, discuss the highlights, and host a question-and-answer session.
The conference call and webcast can be accessed as follows:
New Date & Time: |
Tuesday, May 31, 2022 at 8:30 a.m. ET |
Telephone: |
Toll-free + 1-833-950-0062 |
Local or International +1-226-828-7575 |
|
Please allow a few minutes to be connected to the conference call. |
|
Access Code: |
575783 |
Webcast: |
Accessible on ShinyBud’s website at investors.shinybud.com/Q42022 |
Note: |
The slide presentation will be available for download at investors.shinybud.com. |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE2 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis1 day ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis1 day ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical